Thermo Fisher Scientific (TMO) Tops Q2 EPS by 25c; Raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Thermo Fisher Scientific (TMO) PT Raised to $655 at Jefferies
July 24, 2024 4:04 PM EDTJefferies analyst Brandon Couillard raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $655.00 (from $650.00) while maintaining a Buy rating.
The analyst comments "TMO delivered solid revenue/EPS upside despite the still choppy demand backdrop. FY guidance was nudged... More
Thermo Fisher Scientific (TMO) PT Raised to $664 at RBC Capital, 'Recovery on Track'
July 24, 2024 12:39 PM EDTRBC Capital analyst Conor McNamara raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $664.00 (from $660.00) while maintaining a Outperform rating.
The analyst comments "Since taking over as the leader of TMO in 2009, CEO Marc Caspar (by our math) has hit or... More
Goldman Sachs Reiterates Buy Rating on Thermo Fisher Scientific (TMO)
July 24, 2024 7:15 AM EDTGoldman Sachs analyst Matthew Sykes reiterated a Buy rating and $650.00 price target on Thermo Fisher Scientific (NYSE: TMO).
The analyst comments "2Q24 bottom line beat with (1%) in organic growth: 2Q revenue of $10.54bn is above Visible Alpha Consensus Data of $10.52bn... More
